DK0820303T3 - p277 peptidanaloger og farmaceutiske sammensætninger, der omfatter dem, til behandling eller diagnosticering af diabetes - Google Patents

p277 peptidanaloger og farmaceutiske sammensætninger, der omfatter dem, til behandling eller diagnosticering af diabetes

Info

Publication number
DK0820303T3
DK0820303T3 DK95944502T DK95944502T DK0820303T3 DK 0820303 T3 DK0820303 T3 DK 0820303T3 DK 95944502 T DK95944502 T DK 95944502T DK 95944502 T DK95944502 T DK 95944502T DK 0820303 T3 DK0820303 T3 DK 0820303T3
Authority
DK
Denmark
Prior art keywords
diabetes
diagnosis
treatment
pharmaceutical compositions
peptide analogs
Prior art date
Application number
DK95944502T
Other languages
Danish (da)
English (en)
Inventor
Dana Elias
Matityahu Fridkin
Irun R Cohen
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0820303(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0820303T3 publication Critical patent/DK0820303T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95944502T 1994-12-21 1995-12-20 p277 peptidanaloger og farmaceutiske sammensætninger, der omfatter dem, til behandling eller diagnosticering af diabetes DK0820303T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
PCT/US1995/016596 WO1996019236A1 (en) 1994-12-21 1995-12-20 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (1)

Publication Number Publication Date
DK0820303T3 true DK0820303T3 (da) 2003-10-06

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95944502T DK0820303T3 (da) 1994-12-21 1995-12-20 p277 peptidanaloger og farmaceutiske sammensætninger, der omfatter dem, til behandling eller diagnosticering af diabetes

Country Status (31)

Country Link
EP (1) EP0820303B1 (pt)
JP (2) JP3420245B2 (pt)
KR (1) KR100400480B1 (pt)
CN (1) CN1233417C (pt)
AR (1) AR002949A1 (pt)
AT (1) ATE242005T1 (pt)
AU (1) AU707835B2 (pt)
BR (1) BR9510102A (pt)
CA (1) CA2208274C (pt)
CZ (1) CZ293784B6 (pt)
DE (2) DE69531004T2 (pt)
DK (1) DK0820303T3 (pt)
ES (1) ES2201137T3 (pt)
FI (1) FI118373B (pt)
HR (1) HRP950612B1 (pt)
HU (1) HU224160B1 (pt)
IL (1) IL116499A0 (pt)
IS (1) IS1966B (pt)
MX (1) MX9704738A (pt)
NO (1) NO317350B1 (pt)
NZ (1) NZ301440A (pt)
PL (1) PL184145B1 (pt)
PT (1) PT820303E (pt)
RO (1) RO116777B1 (pt)
RS (1) RS49517B (pt)
SI (1) SI0820303T1 (pt)
TR (1) TR199501630A2 (pt)
TW (1) TW496872B (pt)
UA (1) UA42040C2 (pt)
UY (1) UY24130A1 (pt)
WO (1) WO1996019236A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
US6451541B1 (en) * 1996-05-14 2002-09-17 Ernst-Ludwig Winnacker Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc
CA2420499A1 (en) * 2000-08-25 2002-02-28 Yeda Research And Development Co. Ltd. Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
EP1575479A4 (en) 2002-01-31 2006-10-25 Develogen Israel Ltd HSP-PEPTIDES AND ANALOGUES FOR MODULATING IMMUNE RESPONSES ON ANY PRESENTING CELLS
WO2005072056A2 (en) * 2004-01-28 2005-08-11 Develogen Israel Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
WO2006072946A2 (en) * 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
JP2008531730A (ja) 2005-03-04 2008-08-14 キュアーディーエム、インク． Ｉ型真性糖尿病及び他の症状を治療するための方法及び薬学的組成物
CA2609667C (en) 2005-05-25 2011-02-22 Curedm, Inc. Human proislet peptide, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2008064306A2 (en) 2006-11-22 2008-05-29 Curedm, Inc. Methods and compositions relating to islet cell neogenesis
BRPI0815308A2 (pt) 2007-08-30 2016-07-19 Curedm Inc peptídeo das pró-ilhotas de lagerhans, composição farmacûtica, método para estimular na neogêneses das ilhotas ou estimular a regeneração das ilhotas de langerhans e método para tratar uma patologia associada com a função pancreática defeituosa em um indivíduo
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
US20150018271A1 (en) 2012-03-01 2015-01-15 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
EP2819689A1 (en) 2012-03-01 2015-01-07 Yeda Research and Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
EP0820303A1 (en) 1998-01-28
NO972849D0 (no) 1997-06-19
DE820303T1 (de) 1999-05-20
HU224160B1 (hu) 2005-06-28
TR199501630A2 (tr) 1996-07-21
HUT78092A (hu) 1999-09-28
NO972849L (no) 1997-08-13
PL321091A1 (en) 1997-11-24
CA2208274C (en) 2005-12-06
FI972669A0 (fi) 1997-06-19
IS1966B (is) 2004-12-15
DE69531004D1 (de) 2003-07-10
AR002949A1 (es) 1998-05-27
PL184145B1 (pl) 2002-09-30
SI0820303T1 (en) 2003-10-31
FI972669A (fi) 1997-08-15
WO1996019236A1 (en) 1996-06-27
EP0820303B1 (en) 2003-06-04
UY24130A1 (es) 1996-06-11
IS4510A (is) 1997-06-19
PT820303E (pt) 2003-10-31
AU4686696A (en) 1996-07-10
ES2201137T3 (es) 2004-03-16
EP0820303A4 (pt) 1998-03-11
MX9704738A (es) 1997-10-31
JP3420245B2 (ja) 2003-06-23
CN1175214A (zh) 1998-03-04
BR9510102A (pt) 1997-11-25
JP2004026797A (ja) 2004-01-29
JPH10511649A (ja) 1998-11-10
FI118373B (fi) 2007-10-31
KR100400480B1 (ko) 2003-12-31
RS49517B (sr) 2006-10-27
NZ301440A (en) 2000-01-28
ATE242005T1 (de) 2003-06-15
NO317350B1 (no) 2004-10-18
DE69531004T2 (de) 2004-02-05
UA42040C2 (uk) 2001-10-15
YU78795A (sh) 1998-05-15
RO116777B1 (ro) 2001-06-29
CA2208274A1 (en) 1996-06-27
TW496872B (en) 2002-08-01
HRP950612A2 (en) 1997-10-31
JP3554319B2 (ja) 2004-08-18
CZ190897A3 (en) 1997-11-12
HRP950612B1 (en) 2003-12-31
IL116499A0 (en) 1996-03-31
CZ293784B6 (cs) 2004-07-14
CN1233417C (zh) 2005-12-28
AU707835B2 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
DK0820303T3 (da) p277 peptidanaloger og farmaceutiske sammensætninger, der omfatter dem, til behandling eller diagnosticering af diabetes
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK462588A (da) 5-hydroxy-3-aminokromanforbindelser, fremgangsmaade til deres fremstilling, farmaceutiske praeparater indeholdende dem og fremgangsmaader til behandling dermed
DK582489D0 (da) Substituerede 2'-deoxy-4'-azido-nucleosider, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende samme
IT1207508B (it) Procedimento per la preparazione di silibinina esente da isosilibina e medicamenti contenenti dilibinina.
DK531387A (da) 3-propenylcephemderivater, mellemprodukter til anvendelse ved fremstillingen heraf og praeparater indeholdende foerstnaevnte forbindelser.
NO971517D0 (no) Peptider og farmasöytiske sammensetninger omfattende dem
DK1222921T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
DK523587D0 (da) Kompositmateriale til medicinsk eller paramedicinsk, isaer ortopaedisk anvendelse
DK187989A (da) Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf
DK347789D0 (da) Cysteinderivater, fremgangsmaade til fremstilling af dem og farmaceutiske praeparater indeholdende saadanne forbindelser
ZA9510828B (en) Peptide p277 analogs and phamarceutical compositions comprising them for treatment or diagnosis of diabetes
DK578683A (da) Cyclopropylsubstituerede polyener, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.
IT8620658A0 (it) Frazione ottenuta da propionibacterium ances avente azione terapeutica immunomodulante, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
DK38288A (da) Sparsomycin (sc-rs) sammensaetninger med antitumoraktivitet, fremgangsmaade til fremstilling deraf og farmaceutiske sammensaetninger indeholdende sparsomycin (sc-rs) sammensaetninger
IL114460A0 (en) Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
DK8893A (da) Medikament til behandling eller forebyggelse af sygdom
IT1168162B (it) Procedimento per la preparazione della n-((s)-1-carbetossi(carbossi)-3-fenilpropil)-(s)-alanil-(s)-prolina, e relativa composizione farmaceutica
NO920620L (no) Polypeptidanaloger av apolipoprotein e, diagnostiske systemer og fremgangsmaater ved anvendelse av analogene
DK621987D0 (da) Middel til forebyggelse eller behandling af kaelvningsfeber
IT8124404A0 (it) Derivato della propionilglina, processi per la sua preparazione e composizioni terapeutiche che lo contengono come principio attivo.